Home › Therapeutic areas › Ophthalmology › Thyroid Eye Disease
Thyroid Eye Disease (3 companies)
Companies with an active program in Thyroid Eye Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| SEPN | Septerna | ImmunologyMetabolic+1 Rare | 1 | Phase 1 | $2.28B | 5 |
| VRDN | Viridian Therapeutics | ImmunologyOphthalmology | 3 | Approved | $3.24B | 7 |
| ZBIO | Zenas BioPharma | DermatologyImmunology+2 Rare | 1 | NDA Submitted | $1.92B | 11 |
No companies match.